David Elsbree Net Worth & Insider Trades

David Elsbree - Director, T2 Biosystems, Inc

As of June 28, 2022

What is David Elsbree's Net Worth?

The current estimated net worth of T2 Biosystems, Inc's Director, David Elsbree, is estimated to be about $29.45K . David Elsbree owns about 101,081 units of T2 Biosystems, Inc common stock. In the last 8 years at T2 Biosystems, Inc, David Elsbree has sold an estimated value of $11.35K worth.

What is David Elsbree's Past Insider Trading?

David Elsbree's largest purchase order was 6,250 units , worth over $102.94K on May 21, 2015. David Elsbree's largest sale order was 5,316 units , worth over $6.17K on January 7, 2020. In total, David Elsbree has made about 24 transactions over 8 years of their time at T2 Biosystems, Inc. David Elsbree usually trades in June, with the busiest year in 2015.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is David Elsbree's' Mailing Address?

  • Mailing address is C/o Acme Packet, Inc. 100 Crosby Drive Bedford MA 01730 MA

T2 Biosystems, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John Sperzel, 2020 $490,705 - - $2,571,384 $393,750 $3,000 $3,458,839
John McDonough, 2020 $72,906 - $74,999 - - $1,022,182 $1,170,087
John McDonough, 2019 $550,000 - $372,000 $478,728 $233,750 $3,000 $1,637,478
Alec Barclay, 2020 $340,000 - $25,675 $38,621 $234,600 $952 $639,848
Alec Barclay, 2019 $337,500 $35,000 $111,600 $348,834 $102,000 $2,900 $937,834
Anthony Pare, 2020 $325,000 - $20,738 $159,763 $185,250 $3,000 $693,751
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm

What are T2 Biosystems, Inc's Past Insider Trades?

T2 Biosystems, Inc's most recent insider trade came on April 11, 2022 by John Sperzel III who bought 30,000 units worth $15K . In the last 8 years, insiders at T2 Biosystems, Inc have sold an estimated value of $9.08M and bought an estimated value of $60.75M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Thomas Lowery, Chief Scientific Officer,  David Elsbree, Director,  and Terrence Michael Gibbs, General Counsel .

T2 Biosystems, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1